Sigyn Therapeutics, Inc.
SIGY
$4.15
$0.153.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -522.80K | -1.20M | -862.40K | -758.10K | -1.18M |
| Total Depreciation and Amortization | 1.40K | 1.40K | 1.40K | 1.50K | 3.70K |
| Total Amortization of Deferred Charges | 108.10K | 362.80K | 259.00K | 126.60K | 582.60K |
| Total Other Non-Cash Items | -26.20K | 292.50K | 37.50K | 37.50K | -23.00K |
| Change in Net Operating Assets | 149.40K | 376.40K | 381.70K | 356.80K | 484.80K |
| Cash from Operations | -290.20K | -163.80K | -182.80K | -235.60K | -127.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 181.00K | 301.50K | 228.60K | 276.80K | 75.00K |
| Total Debt Repaid | -43.40K | -26.60K | -25.00K | -20.00K | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 137.60K | 275.00K | 203.60K | 256.80K | 75.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -152.60K | 111.10K | 20.80K | 21.10K | -52.90K |